7-Fluoro-6-Nitroquinazolin-4(1H)-one CAS 162012-69-3 Puritas >99.0% (HPLC)

Description:

Nomen chemicum: 7-Fluoro-6-Nitroquinazolin-4(1H)-one

CAS: 162012-69-3

Puritas: >99.0% (HPLC)

Yellow vel rufo flavo Crystal aut pulveris

Afatinib Dimaleate (CAS: 850140-73-7)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 7-Fluoro-6-Nitroquinazolin-4(1H)-one
Synonyma 7-Fluoro-6-Nitroquinazolin-4(3H)-one;7-Fluoro-4-Hydroxy-6-Nitroquinazoline;7-Fluoro-6-Nitroquinazolin-4-ol;7-Fluoro-6-Nitro-4-Hydroxyquinazoline;7-Fluoro-6-Nitro-1H-Quinazolin-4-one
CAS Number 162012-69-3
CATTUS Number RF-PI2025
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H4FN3O3
M. Pondus 209.13
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Yellow vel rufo flavo Crystal aut pulveris
1 H NMR Spectrum Congruunt cum Structure
Puritas / Analysis Methodus >99.0% (HPLC)
Damnum in Siccatio <0.50%
Totalis immunditias <1.00%
Proton NMR Spectrum Conformat ut Structure
Test Standard Enterprise Standard
Consuetudinem Afatinib Dimaleate (CAS: 850140-73-7)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

7-Fluoro-6-Nitroquinazolin-4(1H)-unum (CAS: 162012-69-3) medium est Afatinib Dimaleate (CAS: 850140-73-7).Afatinib irreversibilis est familia interclusorum ErbB qui informationes transmissionis supprimunt et vias maiores impeditas quae in incremento et divisione cellae cancri implicantur.Quia ErbB familiae informationes transductionis mechanismi possunt per plures homodimersos et heterodimeros Urguere, simultanea inhibitio plurium membrorum familiarium ErbB (ut EGFR, HER2, ErbB3 et ErbB4) efficaciter interrumpens informationes transductionem amni possunt.Afatinib est medicamentum approbatum ad tractationem carcinomatis pulmonis non parvae cellulae (NSCLC), a Boehringer Ingelheim evoluta.Agit angiokinase inhibitor.Sicut lapatinib et neratinib, afatinib est tyrosinus kinasus inhibitor (TKI) qui etiam irrevocabiliter vetat factorem 2 (Her2) et factor incrementi epidermalis receptor 2 (Her2) et kinases receptae incrementi epidermalis.Afatinib non solum activa contra mutationes EGFR iaculis a generatione prima TKIs likeerlotinib vel gefitinib, sed etiam contra illas therapias normas non sensitivas.Propter additam actionem contra Her2, investigatur pro carcinomate pectoris necnon aliis EGFR et Her2 carcinomata agitata.

Epistulam tuam hic scribe et mitte nobis